A Curated Platform of Equity & Options Market Intelligence
Select Page

CDNA

Search by
TICKER SYMBOL

Caredx Inc

Sector: Health Care and Social Assistance
Industry: Medical Laboratories

12.01

1.37

(12.876%)

Volume:

2,438,446

52 week range:

4.8 - 12.93

Market Cap:

621.86M

Company Description:

caredx: transforming transplant patient care through novel surveillance management solutions caredx, inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. by combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, caredx is at the forefront of organ transplant surveillance and pre-transplant hla typing solutions. nasdaq:cdna about allosure® allosure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. allosure is a clinical-grade, proprietary next-generation sequencing (ngs) based test to detect donor-derived cell-free dna (dd-cfdna) in order to identify organ injury in kidney transplant recipients. allosure is analytically validated as a sensitive, specific, and precise measurement of dd-cfdna. allos